Bank of America Corporation »

Prelude Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2024-03-31 $153k 32k 4.74
2023-12-31 $160k 38k 4.27
2023-09-30 $163k 53k 3.09
2023-06-30 $52k 12k 4.50
2023-03-31 $161k 28k 5.70
2022-12-31 $953k 158k 6.04
2022-06-30 $697k 134k 5.22
2021-12-31 $977k 79k 12.45
2021-06-30 $145k 5.0k 28.80
2021-03-31 $711k 16k 43.29
2020-12-31 $35k 490 71.17
2020-09-30 $0 10 0.00